# Non-inferiority Study of GSK Biologicals' Influenza Vaccine GSK576389A Using Different Formulations

> **NCT00633074** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 720 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Thiomersal-free FluAS25 adjuvanted vaccine (GSK576389A)
- **BIOLOGICAL:** Thiomersal reduced FluAS25 adjuvanted vaccine (GSK576389A)

## Key facts

- **NCT ID:** NCT00633074
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03-03
- **Primary completion:** 2008-04-11
- **Final completion:** 2008-04-11
- **Target enrollment:** 720 (ACTUAL)
- **Last updated:** 2018-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00633074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00633074, "Non-inferiority Study of GSK Biologicals' Influenza Vaccine GSK576389A Using Different Formulations". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00633074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*